UnitedHealth Group Incorporated (NYSE:UNH) had its price target upped by research analysts at Citigroup Inc. from $195.00 to $213.00 in a report issued on Wednesday, July 19th. The brokerage currently has a “buy” rating on the healthcare conglomerate’s stock. Citigroup Inc.’s price objective suggests a potential upside of 9.29% from the company’s previous close.
Other research analysts have also recently issued reports about the company. Deutsche Bank AG began coverage on UnitedHealth Group in a report on Wednesday, April 5th. They issued a “buy” rating and a $183.00 price target for the company. UBS AG reaffirmed a “buy” rating and issued a $194.00 price target (up from $193.00) on shares of UnitedHealth Group in a report on Saturday, April 22nd. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $205.00 price target (up from $200.00) on shares of UnitedHealth Group in a report on Saturday, April 22nd. Sanford C. Bernstein reaffirmed an “outperform” rating and issued a $190.00 price target on shares of UnitedHealth Group in a report on Monday, July 10th. Finally, Credit Suisse Group reiterated an “outperform” rating and issued a $200.00 price objective (up from $195.00) on shares of UnitedHealth Group in a research report on Thursday, July 13th. One equities research analyst has rated the stock with a hold rating and twenty-four have given a buy rating to the company. UnitedHealth Group currently has an average rating of “Buy” and a consensus target price of $200.24.
UnitedHealth Group (UNH) opened at 194.90 on Wednesday. UnitedHealth Group has a 12 month low of $132.39 and a 12 month high of $194.99. The company has a market cap of $191.98 billion, a price-to-earnings ratio of 23.41 and a beta of 0.64. The company has a 50-day moving average of $186.80 and a 200-day moving average of $173.05.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.38 by $0.08. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The company had revenue of $50.05 billion during the quarter, compared to analysts’ expectations of $49.97 billion. During the same period last year, the business earned $1.96 earnings per share. The business’s revenue was up 7.7% on a year-over-year basis. Analysts predict that UnitedHealth Group will post $9.87 EPS for the current year.
COPYRIGHT VIOLATION WARNING: “UnitedHealth Group Incorporated (NYSE:UNH) PT Raised to $213.00” was posted by StockNewsTimes and is the property of of StockNewsTimes. If you are accessing this piece on another site, it was illegally stolen and republished in violation of U.S. & international copyright and trademark law. The correct version of this piece can be viewed at https://stocknewstimes.com/2017/08/09/citigroup-inc-boosts-unitedhealth-group-incorporated-nyseunh-price-target-to-213-00-updated-updated.html.
In related news, Director William C. Ballard, Jr. sold 5,000 shares of the business’s stock in a transaction that occurred on Thursday, August 3rd. The stock was sold at an average price of $193.98, for a total transaction of $969,900.00. Following the transaction, the director now directly owns 76,058 shares of the company’s stock, valued at approximately $14,753,730.84. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Gail R. Wilensky sold 5,540 shares of the business’s stock in a transaction that occurred on Friday, June 2nd. The stock was sold at an average price of $178.74, for a total value of $990,219.60. Following the transaction, the director now directly owns 60,516 shares in the company, valued at $10,816,629.84. The disclosure for this sale can be found here. Insiders sold a total of 15,540 shares of company stock worth $2,873,320 in the last 90 days. Company insiders own 0.89% of the company’s stock.
Hedge funds and other institutional investors have recently bought and sold shares of the company. A.R.T. Advisors LLC purchased a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $2,224,000. William Blair Investment Management LLC raised its position in shares of UnitedHealth Group by 13.4% in the fourth quarter. William Blair Investment Management LLC now owns 697,694 shares of the healthcare conglomerate’s stock worth $111,659,000 after buying an additional 82,511 shares in the last quarter. Silvercrest Asset Management Group LLC raised its position in shares of UnitedHealth Group by 3.6% in the fourth quarter. Silvercrest Asset Management Group LLC now owns 12,086 shares of the healthcare conglomerate’s stock worth $1,934,000 after buying an additional 424 shares in the last quarter. Girard Securities Inc. purchased a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $248,000. Finally, GSA Capital Partners LLP raised its position in shares of UnitedHealth Group by 93.6% in the fourth quarter. GSA Capital Partners LLP now owns 29,541 shares of the healthcare conglomerate’s stock worth $4,728,000 after buying an additional 14,285 shares in the last quarter. 86.37% of the stock is currently owned by institutional investors and hedge funds.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.
